Fig. 2.

Change from baseline in a CDAI at month 3, b CDAI at month 6, c HAQ-DI at month 3, and d HAQ-DI at month 6. *p < 0.05, **p < 0.001, ***p < 0.0001 vs placebo; Full Analysis Set. BID twice daily, CDAI Clinical Disease Activity Index, CFB change from baseline, HAQ-DI Health Assessment Questionnaire-Disability Index, LSM least squares mean, MTX methotrexate, N number of patients assessed, SE standard error, wk week